Sandrine Flory
Directeur/Bestuurslid bij TRANSGENE
Profiel
Sandrine Flory is currently a Director at Transgene SA, TSGH SAS, GeNeuro SA (Switzerland), and Institut Mérieux SA. She previously worked as the Chief Financial Officer-EMEA Division at bioMérieux SA. Ms. Flory holds a graduate degree from Universite Lumiere Lyon 2.
Actieve functies van Sandrine Flory
Bedrijven | Functie | Begin |
---|---|---|
TRANSGENE | Directeur/Bestuurslid | 01-01-2021 |
GENEURO SA | Directeur/Bestuurslid | 18-03-2024 |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Financieel Directeur/CFO | 01-01-2020 |
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Directeur/Bestuurslid | 01-01-2002 |
Eerdere bekende functies van Sandrine Flory
Bedrijven | Functie | Einde |
---|---|---|
BIOMÉRIEUX | Corporate Officer/Principal | 01-01-2020 |
Opleiding van Sandrine Flory
Universite Lumiere Lyon 2 | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
TRANSGENE | Health Technology |
BIOMÉRIEUX | Health Technology |
GENEURO SA | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Health Technology |
TSGH SAS
TSGH SAS Financial ConglomeratesFinance TSGH SAS operates as an investment holding company. The company is headquartered in Lyon, France. | Finance |